Company Data
MiNK Therapeutics Inc.
Ticker
INKT
Current Price
$9.94 -3.96%
Market Cap
$50.7M
Price Target
Refer to Report
Volume
9.8K
52wk Range
$8.4801 - $16.9267
Overview
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.